Levetiracetam
Product Images NDC 67046-420

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 67046-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 6.jpg (Figure 5.jpg.jpg.jpg.jpg)

A bar chart comparing the percentage of patients between two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis shows the percentage of patients from 0% to 45%. The Placebo group has 19.6%, and the Levetiracetam group has 43.1%, with an asterisk indicating statistical significance for the Levetiracetam group.*

FDA Label Image

Levetiracetam Tablets 500mg 120 Ct Label (Rev 04/17)

Levetiracetam 500 mg tablet pack label showing quantity of 30 tablets. The label indicates the product is packaged by Contract Pharmacy Services-PA. It includes lot number, expiration date, storage conditions, and dosage information directing users to see the package insert. The label features two barcodes and pill identification details.*

FDA Label Image

Image 0 (Levetiracetamtabletscombi Figure 01)

A formula illustrating how to calculate the total daily dose of Levetiracetam oral solution. It shows the calculation of total daily dose in mL/day by dividing the product of daily dose (mg/kg/day) and patient weight (kg) by 100 mg/mL concentration.*

FDA Label Image

Image 1 (Levetiracetamtabletscombi Figure 02)

Text panel showing equations for calculating creatinine clearance (CLcr) adjusting for age, weight, serum creatinine, gender, and body surface area (BSA). It includes the Cockcroft-Gault formula and a BSA adjustment formula for clearance in mL/min/1.73 m².*

FDA Label Image

Image 2 (Levetiracetamtabletscombi Figure 03)

Chemical structure of levetiracetam, showing its molecular configuration with a pyrrolidone ring attached to an ethyl group and an amide functional group.*

FDA Label Image

Image 3 (Levetiracetamtabletscombi Figure 04)

A bar graph showing the percentage of patients for three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The vertical axis represents the percentage of patients, ranging from 0% to 45%. Placebo group shows 7.4%, Levetiracetam 1000 mg/day shows 37.1%, and Levetiracetam 3000 mg/day shows 39.6%, with asterisks indicating statistical significance for the Levetiracetam groups.*

FDA Label Image

Image 4 (Levetiracetamtabletscombi Figure 05)

Bar graph comparing the percentage of patients across three groups: Placebo (N=111) at 6.3%, Levetiracetam 1000 mg/day (N=106) at 20.8%, and Levetiracetam 2000 mg/day at 35.2%. Each bar is labeled with the corresponding percentage and asterisks indicate statistical markers.*

FDA Label Image

Image 5 (Levetiracetamtabletscombi Figure 06)

A bar chart comparing the percentage of patients between two groups: Placebo and Levetiracetam 3000 mg/day with extended release. The Placebo group (N=104) shows approximately 14.4% of patients, while the Levetiracetam group (N=180) shows 39.4% of patients, indicating a higher response percentage for Levetiracetam.*

FDA Label Image

Image 6 (Levetiracetamtabletscombi Figure 07)

Bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The placebo group (N=97) shows 19.6% of patients, while the Levetiracetam group (N=101) shows 44.6% of patients, indicating a higher percentage for Levetiracetam.*

FDA Label Image

Image 7 (Levetiracetamtabletscombi Figure 08)

A bar chart comparing the percentage of patients between two groups: Placebo (N=84) with 45.2% and Levetiracetam (N=79) with 72.2%. The y-axis represents the percentage of patients from 0% to 100%, showing a higher percentage in the Levetiracetam group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.